PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Weber, J.* ; de la Rosa, J.* ; Grove, C.S.* ; Schick, M.* ; Rad, L.* ; Baranov, O.* ; Strong, A.* ; Pfaus, A.* ; Friedrich, M.J.* ; Engleitner, T.* ; Lersch, R.* ; Öllinger, R.* ; Grau, M.* ; Menendez, I.G.* ; Martella, M.* ; Kohlhofer, U.* ; Banerjee, R.* ; Turchaninova, M.A.* ; Scherger, A.* ; Hoffman, G.J.* ; Hess J. ; Kuhn, L. ; Ammon, T.* ; Kim, J.* ; Schneider, G.* ; Unger, K. ; Zimber-Strobl, U. ; Heikenwälder, M.* ; Schmidt-Supprian, M.* ; Yang, F.* ; Saur, D.* ; Liu, P.* ; Steiger, K.* ; Chudakov, D.M.* ; Lenz, G.* ; Quintanilla-Martinez, L.* ; Keller, U.* ; Vassiliou, G.S.* ; Cadiñanos, J.* ; Bradley, A.* ; Rad, R.*

PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice.

Nat. Commun. 10:1415 (2019)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
B-cell lymphoma (BCL) is the most common hematologic malignancy. While sequencing studies gave insights into BCL genetics, identification of non-mutated cancer genes remains challenging. Here, we describe PiggyBac transposon tools and mouse models for recessive screening and show their application to study clonal B-cell lymphomagenesis. In a genome-wide screen, we discover BCL genes related to diverse molecular processes, including signaling, transcriptional regulation, chromatin regulation, or RNA metabolism. Cross-species analyses show the efficiency of the screen to pinpoint human cancer drivers altered by non-genetic mechanisms, including clinically relevant genes dysregulated epigenetically, transcriptionally, or post-transcriptionally in human BCL. We also describe a CRISPR/Cas9-based in vivo platform for BCL functional genomics, and validate discovered genes, such as Rfx7, a transcription factor, and Phip, a chromatin regulator, which suppress lymphomagenesis in mice. Our study gives comprehensive insights into the molecular landscapes of BCL and underlines the power of genome-scale screening to inform biology.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
11.878
2.805
18
27
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cancer Gene Discovery; Sleeping-beauty; Chromosomal Transposition; Insertional Mutagenesis; Therapeutic Targets; Coding Genome; Mouse Model; Pathogenesis; Activation; Mutation
Sprache
Veröffentlichungsjahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Zeitschrift Nature Communications
Quellenangaben Band: 10, Heft: 1, Seiten: , Artikelnummer: 1415 Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Begutachtungsstatus Peer reviewed
Institut(e) Translational Metabolic Oncology (IDC-TMO)
Research Unit Gene Vector (AGV)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Radiation Sciences
Immune Response and Infection
PSP-Element(e) G-501000-001
G-501500-003
DOI 10.1038/s41467-019-09180-3
WOS ID WOS:000462721900014
Scopus ID 85063729846
PubMed ID 30926791
Erfassungsdatum 2019-04-04
[➜Korrektur melden]